Sign In
Buy EW
$86.00
-1.66 (-1.89%)
At Close: Jun 03, 2026
FTC seeks to block Edwards Lifesciences' acquisition of JenaValve
01:41pm, Wednesday, 06'th Aug 2025
The U.S. Federal Trade Commission sued to block Edwards Lifesciences Corp's acquisition of JenaValve Technology Inc, saying in a lawsuit filed in Washington on Wednesday the merger would decrease comp
Edwards Lifesciences Comments on FTC's Action to Block Proposed Acquisition of JenaValve
01:40pm, Wednesday, 06'th Aug 2025
IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) announced today that the U.S. Federal Trade Commission (FTC) moved to block the company's proposed acquisition of JenaValve Technology.
Edwards Lifesciences Stock: Likely To See Sluggish Price Action Through 2027
12:20pm, Wednesday, 06'th Aug 2025
Edwards Lifesciences EW has just entered Phase 18, the final stage of its 18-phase Adhishthana cycle on the weekly chart. While the stock's setup doesn't necessarily point to a bearish outlook, the st
Edwards Lifesciences Lifts 2025 Outlook On Strong First Half Performance
01:49pm, Friday, 25'th Jul 2025
Edwards Lifesciences' EW stock surged Friday following a strong second-quarter 2025 earnings report that saw the medical device innovator surpass revenue and earnings expectations, driven by signific
Edwards Lifesciences Analysts Increase Their Forecasts After Stronger-Than-Expected Q2 Results
09:53am, Friday, 25'th Jul 2025
Edwards Lifesciences Corporation EW reported better-than-expected second-quarter financial results on Thursday.
EW Stock Climbs on Q2 Earnings & Revenue Beat, Margins Down
09:46am, Friday, 25'th Jul 2025
Edwards Lifesciences posts a second-quarter 2025 earnings and revenue beat, with strong growth in TAVR and TMTT segments despite margin pressure.
Edwards Lifesciences Corporation (EW) Q2 2025 Earnings Call Transcript
11:07pm, Thursday, 24'th Jul 2025
Edwards Lifesciences Corporation (NYSE:EW ) Q2 2025 Earnings Conference Call July 24, 2025 5:00 PM ET Company Participants Mark Wilterding - Vice President of Investor Relations Bernard Zovighian - CE
Compared to Estimates, Edwards Lifesciences (EW) Q2 Earnings: A Look at Key Metrics
07:01pm, Thursday, 24'th Jul 2025
The headline numbers for Edwards Lifesciences (EW) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Stree
Edwards Lifesciences raises annual sales forecast on strong demand for heart devices
04:53pm, Thursday, 24'th Jul 2025
Edwards Lifesciences raised its 2025 sales forecast on Thursday, citing strong demand for its artificial heart valves and other medical devices, after posting better-than-expected results for the seco
Edwards Lifesciences Surges 8% On Hiked Guidance, Quarterly Beat
04:31pm, Thursday, 24'th Jul 2025
Edwards Lifesciences stock jumped late Thursday after the medtech company beat second-quarter forecasts and hiked its outlook.
Edwards Lifesciences Reports Second Quarter Results
04:15pm, Thursday, 24'th Jul 2025
IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended June 30, 2025. Recent Highlights Q2 sales grew 11.9% to $1.53 billion, or 10.6%
Robust TMTT Growth to Drive Edwards Lifesciences' Q2 Earnings
08:45am, Tuesday, 22'nd Jul 2025
EW's Q2 earnings report is likely to benefit from soaring TMTT sales, with the segment expected to jump over 57% year over year.
Curious about Edwards Lifesciences (EW) Q2 Performance? Explore Wall Street Estimates for Key Metrics
10:21am, Monday, 21'st Jul 2025
Besides Wall Street's top-and-bottom-line estimates for Edwards Lifesciences (EW), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared dur
Should You Add Edwards Lifesciences Stock to Your Portfolio Now?
09:31am, Friday, 18'th Jul 2025
EW gains traction with surgical tech and TAVR growth, but macro pressures and FX headwinds weigh on margins.
Edwards Lifesciences to Host Earnings Conference Call on July 24, 2025
07:05am, Friday, 18'th Jul 2025
IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended June 30, 2025 after the market closes on Thursday July 24, 2025, and will
